Comparative immunogenicity and efficacy of equivalent outer membrane vesicle and glycoconjugate vaccines against nontyphoidal Salmonella

Comparative immunogenicity and efficacy of equivalent outer membrane vesicle and glycoconjugate vaccines against nontyphoidal Salmonella

Nontyphoidal Salmonellae cause a devastating burden of invasive disease in sub-Saharan Africa with high levels of antimicrobial resistance. Vaccination has potential for a major global health impact, but no licensed vaccine is available. The lack of commercial incentive makes simple, affordable tech...

Descrizione completa

Dettagli Bibliografici
Autori principali:	Micoli, F, Rondini, S, Alfini, R, Lanzilao, L, Necchi, F, Negrea, A, Rossi, O, Brandt, C, Clare, S, Mastroeni, P, Rappuoli, R, Saul, A, Maclennan, C
Natura:	Journal article
Lingua:	English
Pubblicazione:	National Academy of Sciences 2018

Documenti analoghi

Strain selection for generation of O-antigen-based glycoconjugate vaccines against invasive nontyphoidal salmonella disease
di: Lanzilao, L, et al.
Pubblicazione: (2015)

Immunogenicity of a bivalent adjuvanted glycoconjugate vaccine against salmonella typhimurium and salmonella enteritidis.
di: Fiorino, F, et al.
Pubblicazione: (2017)

Strain Selection for Generation of O-Antigen-Based Glycoconjugate Vaccines against Invasive Nontyphoidal Salmonella Disease.
di: Luisa Lanzilao, et al.
Pubblicazione: (2015-01-01)

Characterization of O-antigen delivered by generalized modules for membrane antigens (GMMA) vaccine candidates against nontyphoidal Salmonella
di: De Benedetto, G, et al.
Pubblicazione: (2016)

Relationship between antibody susceptibility and lipopolysaccharide O-antigen characteristics of invasive and gastrointestinal nontyphoidal Salmonellae isolates from Kenya.
di: Robert S Onsare, et al.
Pubblicazione: (2015-03-01)

The influence of conjugation variables on the design and immunogenicity of a glycoconjugate vaccine against Salmonella Typhi.
di: Arcuri, M, et al.
Pubblicazione: (2017)

The influence of conjugation variables on the design and immunogenicity of a glycoconjugate vaccine against Salmonella Typhi.
di: M Arcuri, et al.
Pubblicazione: (2017-01-01)

Toll-like receptor activation by generalized modules for membrane antigens from lipid a mutants of salmonella enterica serovars typhimurium and enteritidis
di: Rossi, O, et al.
Pubblicazione: (2016)

Immunogenicity and Induction of Functional Antibodies in Rabbits Immunized with a Trivalent Typhoid-Invasive Nontyphoidal Salmonella Glycoconjugate Formulation
di: Scott M. Baliban, et al.
Pubblicazione: (2018-07-01)

IgG responses to porins and lipopolysaccharide within an outer membrane-based vaccine against nontyphoidal salmonella develop at discordant rates
di: Schager, A, et al.
Pubblicazione: (2018)

Design of a Glycoconjugate Vaccine Against <i>Salmonella</i> Paratyphi A
di: Renzo Alfini, et al.
Pubblicazione: (2024-11-01)

Sugar-protein connectivity impacts on the immunogenicity of site-selective salmonella O-antigen glycoconjugate vaccines
di: Stefanetti, G, et al.
Pubblicazione: (2010)

Invasive nontyphoidal salmonella disease in Africa
di: Gilchrist, J, et al.
Pubblicazione: (2019)

Impact and Control of Sugar Size in Glycoconjugate Vaccines
di: Giuseppe Stefanetti, et al.
Pubblicazione: (2022-09-01)

Development of a glycoconjugate vaccine to prevent meningitis in Africa caused by meningococcal serogroup X.
di: Micoli, F, et al.
Pubblicazione: (2013)

IgG Responses to Porins and Lipopolysaccharide within an Outer Membrane-Based Vaccine against Nontyphoidal <italic toggle="yes">Salmonella</italic> Develop at Discordant Rates
di: Anna E. Schager, et al.
Pubblicazione: (2018-05-01)

Outer membrane vesicle vaccines
di: Micoli, F, et al.
Pubblicazione: (2020)

Exploring the variables influencing the immune response of traditional and innovative glycoconjugate vaccines
di: Francesca Micoli, et al.
Pubblicazione: (2023-05-01)

The <i>Salmonella</i> Paratyphi A O-Antigen Glycoconjugate Vaccine Is Able to Induce Antibodies with Bactericidal Activity Against a Panel of Clinical Isolates
di: Marika Pinto, et al.
Pubblicazione: (2025-01-01)

Nontyphoidal salmonella disease: Current status of vaccine research and development.
di: Tennant, S, et al.
Pubblicazione: (2016)

GMMA and Glycoconjugate Approaches Compared in Mice for the Development of a Vaccine against <i>Shigella flexneri</i> Serotype 6
di: Maria Michelina Raso, et al.
Pubblicazione: (2020-04-01)

Testing a Recombinant Form of Tetanus Toxoid as a Carrier Protein for Glycoconjugate Vaccines
di: Davide Oldrini, et al.
Pubblicazione: (2023-11-01)

A systematic review of the incidence, risk factors and case fatality rates of invasive Nontyphoidal Salmonella (iNTS) Disease in Africa (1966 to 2014)
di: Uche, I, et al.
Pubblicazione: (2017)

O:2-CRM(197) conjugates against Salmonella Paratyphi A.
di: Francesca Micoli, et al.
Pubblicazione: (2012-01-01)

The background, role and approach for development of a controlled human infection model for nontyphoidal Salmonella
di: MacLennan, CA
Pubblicazione: (2021)

Current perspectives on invasive nontyphoidal Salmonella disease
di: Haselbeck, A, et al.
Pubblicazione: (2017)

Cytokine profiles during invasive nontyphoidal Salmonella disease predict outcome in African children.
di: Gilchrist, J, et al.
Pubblicazione: (2016)

Cytokine profiles during invasive nontyphoidal Salmonella disease predict outcome in African children.
di: Gilchrist, J, et al.
Pubblicazione: (2016)

A Systematic Review of the Incidence, Risk Factors and Case Fatality Rates of Invasive Nontyphoidal Salmonella (iNTS) Disease in Africa (1966 to 2014).
di: Ifeanyi Valentine Uche, et al.
Pubblicazione: (2017-01-01)

Risk of nontyphoidal Salmonella bacteraemia in African children is modified by STAT4
di: James J. Gilchrist, et al.
Pubblicazione: (2018-03-01)

Risk of nontyphoidal Salmonella bacteraemia in African children is modified by STAT4
di: Gilchrist, JJ, et al.
Pubblicazione: (2018)

Immunogenicity and immune memory of a nonadjuvanted quadrivalent meningococcal glycoconjugate vaccine in infants.
di: Perrett, K, et al.
Pubblicazione: (2009)

Dissecting the contribution of O-Antigen and proteins to the immunogenicity of Shigella sonnei generalized modules for membrane antigens (GMMA)
di: Francesca Mancini, et al.
Pubblicazione: (2021-01-01)

Protein Carriers for Glycoconjugate Vaccines: History, Selection Criteria, Characterization and New Trends
di: Francesca Micoli, et al.
Pubblicazione: (2018-06-01)

Presentation of life-threatening invasive nontyphoidal Salmonella disease in Malawian children: A prospective observational study
di: MacLennan, C, et al.
Pubblicazione: (2017)

Dose response for Salmonella Typhimurium and Enteritidis and other nontyphoid enteric salmonellae
di: Peter F.M. Teunis
Pubblicazione: (2022-12-01)

Contribution of factor H-Binding protein sequence to the cross-reactivity of meningococcal native outer membrane vesicle vaccines with over-expressed fHbp variant group 1
di: Marini, A, et al.
Pubblicazione: (2017)

Immunogenicity of a tetravalent meningococcal glycoconjugate vaccine in infants: a randomized controlled trial.
di: Snape, MD, et al.
Pubblicazione: (2008)

Complementary measurement of nontyphoidal Salmonella-specific IgG and IgA antibodies in oral fluid and serum
di: Sean C. Elias, et al.
Pubblicazione: (2023-01-01)

Combined effects of glycan chain length and linkage type on the immunogenicity of glycoconjugate vaccines
di: Chakkumkal Anish, et al.
Pubblicazione: (2021-12-01)